|
1
|
Blomme B, Deroanne C, Hulin A, Lambert C,
Defraigne JO, Nusgens B, Radermecker M and Colige A: Mechanical
strain induces a pro-fibrotic phenotype in human mitral valvular
interstitial cells through RhoC/ROCK/MRTF-A and Erk1/2 signaling
pathways. J Mol Cell Cardiol. 135:149–159. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zhao L and Wang Z: MicroRNAs: Game
changers in the regulation of α-synuclein in Parkinson's disease.
Parkinsons Dis. 2019:17431832019.PubMed/NCBI
|
|
3
|
Zhao X, Chen GQ and Cao GM: Abnormal
expression and mechanism of miR-330-3p/BTG1 axis in hepatocellular
carcinoma. Eur Rev Med Pharmacol Sci. 23:6888–6898. 2019.PubMed/NCBI
|
|
4
|
Yang L, Hong Q, Xu SG, Kuang XY, Di GH,
Liu GY, Wu J, Shao ZM and Yu SJ: Downregulation of transgelin 2
promotes breast cancer metastasis by activating the reactive oxygen
species/nuclear factor-κB signaling pathway. Mol Med Rep.
20:4045–4258. 2019.PubMed/NCBI
|
|
5
|
Lin JS, Piper MA, Perdue LA, Rutter C,
Webber EM, O'Connor E, Smith N and Whitlock EP: Screening for
colorectal cancer: A systematic review for the U.S. Preventive
Services Task Force. Agency for Healthcare Research and Quality
(US). (Rockville, MD). 2016.
|
|
6
|
Brenner H, Kloor M and Pox CP: Colorectal
cancer. Lancet. 383:1490–1502. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Koliarakis I, Psaroulaki A, Nikolouzakis
TK, Kokkinakis M, Sgantzos M, Goulielmos G, Androutsopoulos VP,
Tsatsakis A and Tsiaoussis J: Intestinal microbiota and colorectal
cancer: A new aspect of research. J BUON. 23:1216–1234.
2018.PubMed/NCBI
|
|
8
|
Lin F, Zhang P, Zuo Z, Wang F, Bi R, Shang
W, Wu A, Ye J, Li S, Sun X, et al: Thioredoxin-1 promotes
colorectal cancer invasion and metastasis through crosstalk with
S100P. Cancer Lett. 401:1–10. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Nieto MA, Huang RY, Jackson RA and Thiery
JP: EMT: 2016. Cell. 166:21–45. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Derynck R and Weinberg RA: EMT and cancer:
More than meets the eye. Dev Cell. 49:313–316. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Xu D, Li J, Li RY, Lan T, Xiao C and Gong
P: PD-L1 expression is regulated by NF-κB during EMT signaling in
gastric carcinoma. Onco Targets Ther. 12:10099–10105. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Szeder B, Tárnoki-Zách J, Lakatos D, Vas
V, Kudlik G, Merő B, Koprivanacz K, Bányai L, Hámori L, Róna G, et
al: Absence of the Tks4 scaffold protein induces
epithelial-mesenchymal transition-like changes in human colon
cancer cells. Cells. 8:13432019. View Article : Google Scholar
|
|
13
|
Zhang HD, Jiang LH, Sun DW, Li J and Ji
ZL: The role of miR-130a in cancer. Breast Cancer. 24:521–527.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Mellis D and Caporali A: MicroRNA-based
therapeutics in cardiovascular disease: Screening and delivery to
the target. Biochem Soc Trans. 46:11–21. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Di Leva G, Garofalo M and Croce CM:
MicroRNAs in cancer. Annu Rev Pathol. 9:287–314. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Li Y, Zhang G, Wu B, Yang W and Liu Z:
miR-199a-5p represses protective autophagy and overcomes
chemoresistance by directly targeting DRAM1 in acute myeloid
leukemia. J Oncol. 2019:56134172019. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Qu D, Yang Y and Huang X: miR-199a-5p
promotes proliferation and metastasis and epithelial-mesenchymal
transition through targeting PIAS3 in cervical carcinoma. J Cell
Biochem. 120:13562–13572. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Dai BH, Geng L, Wang Y, Sui CJ, Xie F,
Shen RX, Shen WF and Yang JM: microRNA-199a-5p protects hepatocytes
from bile acid-induced sustained endoplasmic reticulum stress. Cell
Death Dis. 4:e6042013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ahmadi A, Khansarinejad B, Hosseinkhani S,
Ghanei M and Mowla SJ: miR-199a-5p and miR-495 target GRP78 within
UPR pathway of lung cancer. Gene. 620:15–22. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhu QD, Zhou QQ, Dong L, Huang Z, Wu F and
Deng X: MiR-199a-5p inhibits the growth and metastasis of
colorectal cancer cells by targeting ROCK1. Technol Cancer Res
Treat. 17:15330346187755092018. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kim BK, Yoo HI, Kim I, Park J and Kim YS:
FZD6 expression is negatively regulated by miR-199a-5p in human
colorectal cancer. BMB Rep. 48:360–366. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Weber C, Alon R, Moser B and Springer TA:
Sequential regulation of alpha 4 beta 1 and alpha 5 beta 1 integrin
avidity by CC chemokines in monocytes: Implications for
transendothelial chemotaxis. J Cell Biol. 134:1063–1073. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Desgrosellier JS and Cheresh DA: Integrins
in cancer: Biological implications and therapeutic opportunities.
Nat Rev Cancer. 10:9–22. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
24
|
Sun CC, Qu XJ and Gao ZH:
Arginine-glycine-aspartate-binding integrins as therapeutic and
diagnostic targets. Am J Ther. 23:e198–e207. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Nagata M, Noman AA, Suzuki K, Kurita H,
Ohnishi M, Ohyama T, Kitamura N, Kobayashi T, Uematsu K, Takahashi
K, et al: ITGA3 and ITGB4 expression biomarkers estimate the risks
of locoregional and hematogenous dissemination of oral squamous
cell carcinoma. BMC Cancer. 13:4102013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Jiao Y, Li Y, Liu S, Chen Q and Liu Y:
ITGA3 serves as a diagnostic and prognostic biomarker for
pancreatic cancer. Onco Targets Ther. 12:4141–4152. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhang H, Cui X, Cao A, Li X and Li L:
ITGA3 interacts with VASP to regulate stemness and
epithelial-mesenchymal transition of breast cancer cells. Gene.
734:1443962020. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Li GF, Li ZB, Zhuang SJ and Li GC:
Inhibition of microRNA-34a protects against propofol
anesthesia-induced neurotoxicity and cognitive dysfunction via the
MAPK/ERK signaling pathway. Neurosci Lett. 675:152–159. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Heo G, Kang D, Park C, Kim SJ, Choo J, Lee
Y, Yoo JW, Jung Y, Lee J, Kim ND, et al: Pro-apoptotic effect of
the novel benzylidene derivative MHY695 in human colon cancer
cells. Oncol Lett. 18:3256–3264. 2019.PubMed/NCBI
|
|
30
|
Fu J, Wu L, Ge C, Xu T, Li D, Fu W, Wang L
and Du J: De-escalating chemotherapy for stage II colon cancer?
Therap Adv Gastroenterol. 12:17562848198675532019. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Luo W, Gao F, Li S and Liu L: FoxM1
promotes cell proliferation, invasion, and stem cell properties in
nasopharyngeal carcinoma. Front Oncol. 8:4832018. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Dhamija S and Diederichs S: From junk to
master regulators of invasion: lncRNA functions in migration, EMT
and metastasis. Int J Cancer. 139:269–280. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Xu TJ, Qiu P, Zhang YB, Yu SY, Xu GM and
Yang W: MiR-148a inhibits the proliferation and migration of
glioblastoma by targeting ITGA9. Hum Cell. 32:548–556. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Norouzinia M, Azodi MZ, Seyfi DN, Kardan
A, Naseh A and Akbari Z: Predication of hub target genes of
differentially expressed microRNAs contributing to infection in
gastric non-cancerous tissue. Gastroenterol Hepatol Bed Bench. 12
(Suppl 1):S44–S50. 2019.PubMed/NCBI
|
|
35
|
Zhang W, Xu J, Wang K, Tang X and He J:
miR1393p suppresses the invasion and migration properties of breast
cancer cells by targeting RAB1A. Oncol Rep. 42:1699–1708. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Dai X, Liang Z, Liu L, Guo K, Xu S and
Wang H: Silencing of MALAT1 inhibits migration and invasion by
sponging miR13p in prostate cancer cells. Mol Med Rep.
20:3499–3508. 2019.PubMed/NCBI
|
|
37
|
Ye K, Xu C and Hui T: MiR-34b inhibits the
proliferation and promotes apoptosis in colon cancer cells by
targeting Wnt/β-catenin signaling pathway. Biosci Rep.
39:BSR201917992019. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Yuan Y, Li N, Zeng L, Shen Z and Jiang C:
Pathogenesis investigation of miR-199-5p in oral submucous fibrosis
based on bioinformatics analysis. Oral Dis. 25:456–465. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Chao CC, Wu PH, Huang HC, Chung HY, Chou
YC, Cai BH and Kannagi R: Downregulation of miR-199a/b-5p is
associated with GCNT2 induction upon epithelial-mesenchymal
transition in colon cancer. FEBS Lett. 591:1902–1917. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Song B, Du J, Feng Y, Gao YJ and Zhao JS:
Co-expressed differentially expressed genes and long non-coding
RNAs involved in the celecoxib treatment of gastric cancer: An RNA
sequencing analysis. Exp Ther Med. 12:2455–2468. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Ura H, Denno R, Hirata K, Yamaguchi K and
Yasoshima T: Separate functions of alpha2beta1 and alpha3beta1
integrins in the metastatic process of human gastric carcinoma.
Surg Today. 28:1001–1006. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Kurokawa A, Nagata M, Kitamura N, Noman
AA, Ohnishi M, Ohyama T, Kobayashi T, Shingaki S, Takagi R; Oral
and Maxillofacial Pathology; Surgery Group, : Diagnostic value of
integrin alpha3, beta4, and beta5 gene expression levels for the
clinical outcome of tongue squamous cell carcinoma. Cancer.
112:1272–1281. 2008. View Article : Google Scholar : PubMed/NCBI
|
